A Danwatch Investigation

Allied with the Ayatollah

Danish pharmaceutical giant Novo Nordisk has chosen to do business in Iran in spite of sanctions and human rights concerns.

Novo has conquered a significant share of the insulin market and opened a factory producing insulin pens.

In the process of entering the Iranian market Novo has allied itself with persons and organisations accused of involvement in serious human rights violations.

Novo has bought land from an organisation founded on the seizure of land from political prisoners, religious minorities and exiled Iranians.

Novo has donated money to a research institute run by the powerful Larijani family, accused of gross human rights violations.

Novo says that all company activities in Iran are in compliance with company guidelines as well as local and international law and regulations.

Experts highlight the dilemma, questioning whether it is possible to do business in Iran without collaborating with controversial persons and organisations.

16. September 2020

Mahtab Dehgan

Journalist / Zamaneh Media

Mahtab Dehgan

Journalist / Zamaneh Media

Editor: Jesper Hyhne | Executive Editor: Jesper Nymark | Need more information about this investigation? Please contact us here

In cooperation with Zamaneh Media
A Danwatch Investigation

The investigation divided into articles. You decide where to begin.

Tip os

Har du en idé, eller har du kendskab til forhold, som du mener, vi bør undersøge – så kontakt os.

Det kan også være, at du er freelancejournalist med en god ide – skriv eller ring.

Jeg vil være anonym

Du kan bruge formularen – også anonymt – men vil du være helt sikker på, at ingen kan spore din kommunikation til os, anbefaler vi, at du installerer app’en Signal på din telefon.

I Signal kan du kontakte os på dette telefonnummer: +45 2340 6664